Drug Side Effects
Search
VORETIGENE NEPARVOVEC-RZYL
VORETIGENE NEPARVOVEC-RZYL
was reported 152 times
VORETIGENE NEPARVOVEC-RZYL is most commonly taken among patients reporting these side effects:
#
Side effect
Count
Frequency
0
SYMPATHETIC OPHTHALMIA
1
0.0625
1
RETINAL FOVEA DISORDER
1
0.0400
2
CHORIORETINAL ATROPHY
8
0.0386
3
RETINAL DEPIGMENTATION
8
0.0261
4
VITREOUS ADHESIONS
2
0.0174
5
LOSS OF VISUAL CONTRAST SENSITIVITY
1
0.0159
6
CHORIORETINAL FOLDS
1
0.0141
7
CENTRAL VISION LOSS
3
0.0135
8
ROSEOLA
1
0.0123
9
RETINAL DEGENERATION
15
0.0115
10
VITREAL CELLS
2
0.0099
11
RETINAL DEPOSITS
2
0.0099
12
RHEGMATOGENOUS RETINAL DETACHMENT
2
0.0096
13
INTRA-OCULAR INJECTION COMPLICATION
2
0.0088
14
BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS
1
0.0062
15
VITREOUS OPACITIES
5
0.0059
16
INTRAOCULAR PRESSURE DECREASED
3
0.0057
17
EYELID INJURY
1
0.0057
18
CHORIORETINAL DISORDER
1
0.0051
19
VISUAL BRIGHTNESS
2
0.0051
20
LENTICULAR OPACITIES
2
0.0046
21
VOGT-KOYANAGI-HARADA DISEASE
1
0.0045
22
SUTURE RELATED COMPLICATION
3
0.0042
23
POST PROCEDURAL FEVER
1
0.0041
24
CATARACT SUBCAPSULAR
2
0.0033
25
RETINAL TEAR
8
0.0032
26
POST PROCEDURAL INFLAMMATION
2
0.0032
27
OCULAR HYPERTENSION
6
0.0031
28
POSTERIOR CAPSULE OPACIFICATION
1
0.0029
29
OPTIC ATROPHY
3
0.0018
30
INTRAOCULAR PRESSURE INCREASED
22
0.0017
31
EPISCLERITIS
1
0.0014
32
ANTERIOR CHAMBER CELL
1
0.0014
33
NIGHT BLINDNESS
2
0.0012
34
RELAPSING-REMITTING MULTIPLE SCLEROSIS
1
0.0012
35
CONJUNCTIVAL HAEMORRHAGE
4
0.0010
36
VITREOUS HAEMORRHAGE
2
0.0007
37
VASCULAR INJURY
1
0.0007
38
PHOTOPSIA
4
0.0006
39
EYE INFLAMMATION
6
0.0006
40
CONJUNCTIVAL HYPERAEMIA
2
0.0006
41
VITRITIS
1
0.0005
42
HUMAN HERPESVIRUS 6 INFECTION
1
0.0005
43
POST PROCEDURAL DISCOMFORT
1
0.0005
44
EYE OEDEMA
1
0.0004
45
STRABISMUS
1
0.0003
46
IRITIS
1
0.0003
47
SUSPECTED COVID-19
1
0.0003
48
VISUAL FIELD DEFECT
2
0.0003
49
TESTIS CANCER
1
0.0003
50
RETINAL DETACHMENT
2
0.0002
51
EYE PAIN
12
0.0002
52
FACE OEDEMA
3
0.0002
53
CATARACT OPERATION
1
0.0002
54
MENTAL IMPAIRMENT
4
0.0002
55
EYE HAEMORRHAGE
2
0.0001
56
OCULAR HYPERAEMIA
7
0.0001
57
EYE MOVEMENT DISORDER
1
0.0001
58
RETINAL HAEMORRHAGE
1
0.0001
59
CATARACT
8
0.0001
60
BLINDNESS
5
0.0001
61
PHOTOPHOBIA
2
0.0001
62
VITREOUS FLOATERS
1
0.0001
63
EYELID PTOSIS
1
0.0001
64
VISUAL IMPAIRMENT
12
0.0001
65
EYE DISCHARGE
1
0.0001
66
PHARYNGITIS STREPTOCOCCAL
1
0.0001
67
VISUAL ACUITY REDUCED
3
0.0001
68
OCULAR DISCOMFORT
1
0.0001
69
METASTASES TO LUNG
1
0.0001
70
DISCOMFORT
5
0.0001
71
PROCEDURAL PAIN
2
0.0001
72
EYE IRRITATION
4
0.0001
73
ANOSMIA
1
0.0001
74
COMPLICATION ASSOCIATED WITH DEVICE
1
0.0001
75
MENINGIOMA
1
0.0001
76
EYE SWELLING
2
0.0001
77
GLAUCOMA
1
0.0001
78
VISION BLURRED
7
0.0001
79
DEPRESSED MOOD
2
0.0000
80
EAR INFECTION
1
0.0000
81
LACRIMATION INCREASED
1
0.0000
82
GAIT INABILITY
1
0.0000
83
EYE PRURITUS
1
0.0000
84
DEVICE DISLOCATION
1
0.0000
85
DISTURBANCE IN ATTENTION
1
0.0000
86
BLISTER
1
0.0000
87
SEIZURE
2
0.0000
88
DISEASE PROGRESSION
2
0.0000
89
ILL-DEFINED DISORDER
1
0.0000
90
VERTIGO
1
0.0000
91
BALANCE DISORDER
1
0.0000
92
OROPHARYNGEAL PAIN
1
0.0000
93
MIGRAINE
1
0.0000
94
ATRIAL FIBRILLATION
1
0.0000
95
PYREXIA
3
0.0000
96
CHILLS
1
0.0000
97
HYPERHIDROSIS
1
0.0000
98
ANXIETY
2
0.0000
99
HEADACHE
4
0.0000
100
MYOCARDIAL INFARCTION
1
0.0000
101
COVID-19
1
0.0000
102
NASOPHARYNGITIS
1
0.0000
103
PRODUCT USE ISSUE
1
0.0000
104
RASH
2
0.0000
105
DRUG INEFFECTIVE
6
0.0000
106
FEELING ABNORMAL
1
0.0000
107
DIZZINESS
2
0.0000
108
INSOMNIA
1
0.0000
109
COUGH
1
0.0000
110
CONDITION AGGRAVATED
1
0.0000
111
OFF LABEL USE
2
0.0000
112
VOMITING
1
0.0000
113
DEATH
1
0.0000